- Home
- IMMX vs HKIT Comparison
IMMX vs HKIT Comparison
Compare IMMX & HKIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMMX | HKIT |
|---|---|---|
| Founded | 2014 | 1996 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 300.9M | 121.6M |
| IPO Year | 2021 | 2023 |
Fundamental Metrics
Financial Performance| Metric | IMMX | HKIT |
|---|---|---|
| Price | $5.67 | $2.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 607.0K |
| Earning Date | 11-07-2025 | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,812,901.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.34 | $1.15 |
| 52 Week High | $7.73 | $4.18 |
Technical Indicators
Market Signals| Indicator | IMMX | HKIT |
|---|---|---|
| Relative Strength Index (RSI) | 56.92 | 59.91 |
| Support Level | $5.33 | $1.42 |
| Resistance Level | $7.73 | $2.59 |
| Average True Range (ATR) | 0.77 | 0.20 |
| MACD | -0.07 | 0.09 |
| Stochastic Oscillator | 48.35 | 66.21 |
Price Performance
Historical ComparisonAbout IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.